Wasan H S, Schofield J B, Krausz T, Sikora K, Waxman J
Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
Cancer. 1994 Feb 1;73(3):514-7. doi: 10.1002/1097-0142(19940201)73:3<514::aid-cncr2820730304>3.0.co;2-7.
A patient with primary adenocarcinoma with yolk sac and trophoblastic differentiation occurring in Barrett's esophagus is reported. Yolk sac differentiation at this site has not been described previously. The diagnosis of germ cell differentiation initially was suggested by the finding of elevated serum tumor marker levels. The patient experienced disease remission after cytotoxic chemotherapy. Germ cell differentiation may be difficult to identify in small biopsy samples, which may not be representative of the tumor as a whole. The finding of germ cell differentiation defines therapy and predicates for a relatively good prognosis, which is contrast to adenocarcinoma. Because of the significance of germ cell differentiation in the selection of appropriate therapy, immunostaining for germ cell tumor markers is suggested in all patients with adenocarcinoma who are younger than 50 years.
本文报道了1例发生于Barrett食管的原发性腺癌伴卵黄囊和滋养层分化的病例。此前尚未见该部位卵黄囊分化的报道。血清肿瘤标志物水平升高这一发现最初提示了生殖细胞分化的诊断。该患者在接受细胞毒性化疗后病情缓解。在小活检样本中可能难以识别生殖细胞分化,因为这些样本可能不代表整个肿瘤。生殖细胞分化的发现决定了治疗方案,并预示着相对较好的预后,这与腺癌形成对比。由于生殖细胞分化在选择合适治疗方法方面具有重要意义,因此建议对所有年龄小于50岁的腺癌患者进行生殖细胞肿瘤标志物的免疫染色。